Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW274150 crossover study in mild asthma with allergen-induced late asthmatic response
2004-000576-13Phase 2Completed
- Sponsor
- GSK
- Start
- Feb 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Sequence including GW274150, Sequence including montelukast and Sequence including placebo (3 arms). Primary endpoint: Late asthmatic response. Started Feb 2005; status: completed.
02
Drugs
GW274150montelukast
03
Conditions
asthma
Beyond the preview
Go deeper on 2004-000576-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000576-13.